Proposed Solution:
It is the small, skilled and resourceful cancer research and treatment teams that will accelerate the pace. CR&T's independence and small size enable it to get things done fast.

CR&T's Unique Role
CR&T moves expeditiously to implement change and help bring research advances as speedily as possible to those patients whose welfare remains its prime concern. The important discoveries made in the laboratory can quickly be applied to help cancer patients.

CR&T has no bureaucracy, no layers of redundant personnel and no endless committees to slow down its progress. It moves swiftly and decisively in the direction it senses will lead to a new treatment or cure.

Through the application of research discoveries to clinical practice, CR&T funding makes a difference at the critical time when promising therapies, which otherwise might be unavailable, are being tested and lives can be saved. Today, CR&T supports a full range of cancer research including: leukemia, myeloma, lymphoma, lung cancer, breast cancer, gastro-intestinal cancers, genitourinary cancers and other liquid and solid tumors. In addition, it participates in cancer prevention trials and companion studies which address quality of life issues such as pain management.

CR&T supported teams and specialists collaborate with pharmaceutical corporations that develop and test particular agents for specific outcomes. Pharmaceutical companies provide CR&T associates with experimental drugs for patients on protocol free of charge and furnish financial support on a per-patient basis for the scientific conduct of these studies. In selecting studies, CR&T physicians and scientists look for promising new drugs, therapies and combinations in cutting-edge research to address the current gaps in clinical knowledge.

In this way, not only are today's patients provided with state-of-the-art treatment, but tomorrow's patients may very well be treated with the cure. CR&T accomplishes all this through the physician-researchers who participate in CR&T studies, as well as by supporting a hard-working team of oncologists, research fellows, data managers, nurse oncologists and an administrator at the Center for the Study of Leukemia and Myeloproliferative Diseases.

As an inter-disciplinary approach to cancer treatment is maintained, other oncologists, surgeons, radiologists, basic scientists, pharmacologists and nurses join the effort.